Provided by Tiger Fintech (Singapore) Pte. Ltd.

Imunon, Inc.

0.8503
-0.0373-4.20%
Volume:541.71K
Turnover:471.93K
Market Cap:18.11M
PE:-0.61
High:0.9099
Open:0.8842
Low:0.8500
Close:0.8876
Loading ...

Sector Update: Health Care Stocks Decline Late Afternoon

MT Newswires Live
·
24 May

Sector Update: Health Care Stocks Softer Friday Afternoon

MT Newswires Live
·
24 May

Top Midday Gainers

MT Newswires Live
·
24 May

Nasdaq Down Over 1%; Workday Shares Tumble After Q1 Results

Benzinga
·
23 May

Imunon Stock (IMNN) Rockets on Clinical Trial Results

TIPRANKS
·
23 May

Imunon Reports Prolonged Survival in Study of Potential Ovarian Cancer Treatment; Shares Soar Pre-Bell

MT Newswires Live
·
23 May

Imunon announces data from Phase 2 OVATION 2 study on IMNN-001

TIPRANKS
·
23 May

Imunon announces withdrawal of Form S-1 Registration Statement

TIPRANKS
·
23 May

Imunon Announces Withdrawal of Form S-1 Registration Statement

THOMSON REUTERS
·
23 May

Imunon Inc. Faces Potential Delisting from Nasdaq Due to Non-Compliance with Minimum Stockholders' Equity Requirement

Reuters
·
20 May

Imunon Cut to Hold From Buy by D. Boral Capital

Dow Jones
·
19 May

Imunon Announces Six-Month Data Showing Durability of Protection for Next-Generation DNA Vaccine Platform in Phase 1 Clinical Trial in Covid-19

THOMSON REUTERS
·
15 May

Imunon Inc - Imnn-101 Safe and Well Tolerated With No Serious Adverse Effects

THOMSON REUTERS
·
15 May

Imunon Is Maintained at Buy by D. Boral Capital

Dow Jones
·
13 May

Imunon Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
12 May

Imunon Q1 EPS $(0.28) Beats $(0.35) Estimate

Benzinga
·
12 May

Imunon Inc expected to post a loss of 35 cents a share - Earnings Preview

Reuters
·
09 May

Imunon Is Maintained at Buy by D. Boral Capital

Dow Jones
·
07 May

IMUNON to Hold First Quarter 2025 Financial Results and Business Update Conference Call on Monday, May 12, 2025

GlobeNewswire
·
05 May

Imunon Announces Imnn-001 Abstract Accepted for Oral Presentation at 2025 Asco Annual Meeting

THOMSON REUTERS
·
21 Apr